For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
March 31– April 3, 2019 Georgia World Congress Center, Atlanta GA
Abcam’s expertise supports the creation of high-quality products that meet our global customers’ complex oncology research requirements, including high-throughput immunoassays, immuno-oncology reagents, and custom antibodies. Our world-leading immunoassays and antibodies are essential across multiple applications within drug discovery, diagnostics, and basic research. We partner with our customers, listening closely to their needs, to produce unique, tailor-made solutions.
Discover how our unique reagents are tailor-made for your unique oncology research. We have everything you need for your research to make a global impact including tools for high-throughput biomarker discovery to our custom antibody services capable of progressing your antibody-based diagnostic from conceptualization to market.
Come to our booth to find out about:
FirePlex®-HT offers a rapid, multiplex solution for quantifying 10 protein analytes per well, in 384-well format. Alongside a 2-step, no-wash protocol, FirePlex®-HT is ideally suited for drug discovery screening studies.
Get the perfect antibody for novel biomarker discovery or diagnostic development. With our unique offering of precision, agility, accuracy, and flexibility, as well as our multiplatform approach, we are confident that we are the best option for you.
Our immuno-oncology (IO) portfolio
Find out more about our broad range of immuno-oncology research tools. This year at AACR we will be showcasing our PD-L1 trial-size bundle pack, our new range of IO IHC panels, and our pan-TRK recombinant monoclonal antibodies.